“The 31-GEP Stratifies Risk of Death in Patients With Stage I-IIA Cutaneous Melanoma: A SEER Real-World Evidence Study”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 4, July 2025, p. s586, https://doi.org/10.25251/ys9mt689.